A Dose Escalation and Safety Study of I5NP in Patients Undergoing Major Cardiovascular Surgery

Clinical trial NCT00554359 · COMPLETED

Trial details

NCT number: NCT00554359
Sponsor: Quark Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Injury of Kidney Acute Renal Failure

Start date: 2007-08-01
Primary completion: 2010-10-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.